|
FAM72B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.095800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.500650E-01 |
| Normal-vs-Stage2 |
1.006190E-02 |
| Normal-vs-Stage3 |
6.758200E-02 |
| Normal-vs-Stage4 |
1.132630E-01 |
| Stage1-vs-Stage2 |
8.9880999998293E-07 |
| Stage1-vs-Stage3 |
1.304600E-01 |
| Stage1-vs-Stage4 |
6.064600E-01 |
| Stage2-vs-Stage3 |
4.801000E-03 |
| Stage2-vs-Stage4 |
1.345670E-02 |
| Stage3-vs-Stage4 |
6.101600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.386370E-01 |
| Normal-vs-AfricanAmerican |
2.902400E-02 |
| Normal-vs-Asian |
8.283700E-02 |
| Caucasian-vs-AfricanAmerican |
1.282300E-02 |
| Caucasian-vs-Asian |
3.404000E-01 |
| AfricanAmerican-vs-Asian |
2.067400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.186100E-02 |
| Normal-vs-Female |
1.068620E-01 |
| Male-vs-Female |
2.454400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.907200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.242300E-02 |
| Normal-vs-Age(61-80Yrs) |
5.973800E-02 |
| Normal-vs-Age(81-100Yrs) |
9.968400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.659100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.502100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.637420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.089000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.490200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.525600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.554800E-01 |
| Classical-VS-Follicular |
8.083900E-03 |
| Classical-VS-Other |
2.231000E-01 |
| Classical-VS-Normal |
1.305250E-01 |
| Tall-VS-Follicular |
1.751640E-01 |
| Tall-VS-Other |
4.466200E-01 |
| Tall-VS-Normal |
1.399750E-01 |
| Follicular-VS-Other |
8.246800E-01 |
| Follicular-VS-Normal |
2.942100E-02 |
| Other-VS-Normal |
5.472300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.431600E-02 |
| Normal-vs-N1 |
1.156810E-01 |
| N0-vs-N1 |
2.531000E-01 |
|
|
